| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,690 |
5,871 |
$445K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,965 |
3,722 |
$360K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,975 |
3,427 |
$333K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,133 |
2,822 |
$307K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,864 |
7,210 |
$283K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,659 |
2,568 |
$246K |
| D0145 |
Oral evaluation for a patient under three years of age |
2,532 |
2,351 |
$90K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
791 |
749 |
$78K |
| D1206 |
Topical application of fluoride varnish |
2,358 |
2,239 |
$51K |
| 92551 |
|
4,944 |
4,682 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,792 |
2,132 |
$21K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
210 |
198 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
498 |
455 |
$15K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
151 |
149 |
$13K |
| 80061 |
Lipid panel |
829 |
780 |
$10K |
| 99460 |
|
106 |
103 |
$9K |
| 99173 |
|
4,909 |
4,651 |
$9K |
| 83655 |
|
748 |
713 |
$9K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
227 |
217 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
227 |
195 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
550 |
262 |
$8K |
| 99442 |
|
194 |
181 |
$7K |
| 96161 |
|
2,670 |
2,282 |
$5K |
| 87634 |
|
54 |
45 |
$3K |
| T1023 |
Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter |
146 |
144 |
$3K |
| 87807 |
|
162 |
144 |
$2K |
| 99462 |
|
37 |
37 |
$1K |
| 0071A |
|
31 |
31 |
$1K |
| 96160 |
|
675 |
637 |
$1K |
| 0002A |
|
32 |
32 |
$1K |
| 85048 |
|
348 |
314 |
$879.83 |
| 0001A |
|
24 |
24 |
$782.57 |
| 96380 |
|
35 |
34 |
$615.40 |
| 0072A |
|
12 |
12 |
$430.44 |
| 85018 |
|
411 |
392 |
$273.69 |
| 90670 |
|
2,232 |
2,123 |
$230.14 |
| 90707 |
|
923 |
884 |
$78.68 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
26 |
13 |
$34.80 |
| 90647 |
|
2,179 |
1,864 |
$26.23 |
| 90723 |
|
2,167 |
1,887 |
$0.00 |
| 90716 |
|
937 |
896 |
$0.00 |
| 90696 |
|
138 |
134 |
$0.00 |
| 90686 |
|
3,149 |
2,988 |
$0.00 |
| 90651 |
|
183 |
174 |
$0.00 |
| 90688 |
|
99 |
94 |
$0.00 |
| 91307 |
|
62 |
55 |
$0.00 |
| 90656 |
|
203 |
202 |
$0.00 |
| 90381 |
|
13 |
12 |
$0.00 |
| 90461 |
|
4,414 |
3,909 |
$0.00 |
| 90700 |
|
135 |
133 |
$0.00 |
| 90671 |
|
679 |
368 |
$0.00 |
| 90681 |
|
1,204 |
1,070 |
$0.00 |
| 90633 |
|
1,032 |
990 |
$0.00 |
| 90734 |
|
66 |
63 |
$0.00 |
| 90685 |
|
227 |
223 |
$0.00 |
| 91300 |
|
68 |
61 |
$0.00 |